Skip to main content

GOLDMAN SACHS GROUP INC

Position in CNTA — Centessa Pharmaceuticals plc

CIK 886982 NEW YORK, NY

Position in CNTA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,144,560
+46.9% QoQ
Ownership
0.740%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CNTA Over Time

Shares Held

Position Value (USD)

Derivatives in CNTA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
28,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CNTA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 28,200
2026-03-31 1,144,560
2025-12-31 779,001
2025-09-30 247,555
2025-06-30 559,283
2025-06-30 37,000
2025-03-31 30,000
2025-03-31 401,764
2024-12-31 175,566
2024-09-30 13,055
2024-03-31 55,027
2023-12-31 24,731
2023-09-30 10,650
2023-06-30 10,650
2023-03-31 10,960
2022-12-31 14,993
2022-09-30 16,529
2022-06-30 16,543